Lantronix Inc 's Comment on Competition and Industry Peers
The company focuses on connected transportation solutions aimed at improving customer engagement and expanding market presence. Its strategic priorities include enhancing product offerings, geographic expansion, and targeted acquisitions to strengthen its competitive position and attract new customers. The embedded product portfolio comprises Compute System-on-Module (SoM) and System-in-Package solutions, as well as wired and wireless connectivity products.
September 18, 2024
Lantronix, a global leader in secure data access and management solutions for the Internet of Things (IoT), proudly presented its advanced array of IoT products at two of the industry s most anticipated events: the Global Security Exchange (GSX) held in Orlando and the Integrated Systems Europe (ISE) in London. The company showcased its award-winning switches, routers, gateways, and trackers, underscoring its commitment to empowering digital transformation across various industries. Pioneering IoT Solutions for Modern ChallengesAt both GSX and ISE, Lantronix unveiled their latest innovations, emphasizing the key role of reliable, secure, and scalable IoT solutions in today’s interconnected world. Leveragin...
July 10, 2024
In today s fast-paced technological landscape, companies constantly strive to provide innovative solutions and gain recognition for their industry contributions. Lantronix Inc., a leading provider of secure data access and management solutions for Internet of Things (IoT) devices, has recently been awarded the prestigious 2024 IoT Evolution Business Impact Award by IoT Evolution Magazine. This accolade stems from the remarkable success of Lantronix s E210 Router and its HY-LINE Digital Signage Case Study, which highlights the company s exceptional IoT solutions for global deployment. Moreover, Lantronix has also caught the attention of industry experts with its plans to demonstrate the Percepxion Edge AI Sol...
May 16, 2024
Championing Equal Access in Medical Research: The Coalition for Clinical Trial Equity’s Bold Move In the evolving landscape of healthcare, one immutable truth persists: equitable access is paramount. However, the stark reality is that socio-economic and racial disparities continue to plague the system. Against this backdrop, the Foundation for Sarcoidosis Research (FSR) has unveiled a groundbreaking initiative - the Coalition for Clinical Trial Equity (CCTE) - to dismantle the barriers that disproportionately hinder Black patients from participating in clinical trials. The Perennial Problem Clinical trials are the cornerstone of advancements in medical science, paving the way for breakthroughs in treatment...
Sources:
Lantronix Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Lantronix Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
